Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
Cathie Wood believes in the potential of gene editing. She stated last December that the "biggest upside surprises are going to come from the genomic space."
It's not surprising that Wood's ARK Genomic Revolution ETF (NYSEMKT: ARKG) and ARK Innovation ETF (NYSEMKT: ARKK) have invested heavily in several gene-editing stocks. However, some of those stocks appear to be viewed more favorably than others. Here's why Wood's ETFs are buying two gene-editing stocks but selling another.
Image source: Getty Images.
Source Fool.com
